Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden · Delayed Price · Currency is SEK 5.34
+0.06 (1.14%)
At close: Dec 30, 2025
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 2.11 billion as of December 31, 2025. Its market cap has decreased by -6.32% in one year.
Market Cap
2.11B
Enterprise Value
2.06B
Revenue
55.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.34
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 2.11B, an increase of 838.30%. That is a compound annual growth rate of 16.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.91B |
| Getinge AB | 59.27B |
| Sectra AB | 48.17B |
| Camurus AB | 37.07B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.59B |
| BioArctic AB | 27.78B |
| Elekta AB | 21.80B |